Curtiss-Wright (NYSE: CW) SVP vests 296 RSUs, then sells 140 shares

Rhea-AI Filing Summary

Curtiss-Wright Senior VP & Treasurer Robert F. Freda reported equity award vesting and a small share sale. On March 16, 2026, 296 restricted stock units granted on March 16, 2023 under the 2014 Omnibus Incentive Plan cliff vested and converted into common stock at a $0.00 exercise price.

On March 17, 2026, he sold 140 shares of common stock in open-market transactions at an average price of $678.61 per share. Footnotes explain the sale was made to cover tax obligations in line with company share ownership guidelines, and that he remains in compliance. After the transactions, he directly holds 5,343 common shares, including dividend credits on prior grants.

Insider Trade Summary

Net Seller: 140 shares ($95,005)

Net Sell 3 txns

Insider Freda Robert F

Role Senior VP & Treasurer

Sold 140 shs ($95K)

Type	Security	Shares	Price	Value
Sale	Common Stock	140	$678.61	$95K
Exercise	Restricted Stock Unit	296	$0.00	--
Exercise	Common Stock	296	$0.00	--

Holdings After Transaction: Common Stock — 5,343 shares (Direct); Restricted Stock Unit — 4,269 shares (Direct)

Footnotes (1)

1. These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant. No price on the date of issue. The restricted stock units were granted as an employee benefit transaction. Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.23 to $681.66, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price. Share total includes dividend credits earned on prior outstanding grants.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Freda Robert F

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NORTH CAROLINA 28036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP & Treasurer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		M(1)		296	A	$0(2)	5,483	D
Common Stock	03/17/2026		S(3)		140	D	$678.61(4)	5,343	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0(2)	03/16/2026		M(1)			296	03/16/2026	03/16/2026	Common Stock	296	$0(2)	4,269(5)	D

Explanation of Responses:

1. These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

2. No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

3. Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

4. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.23 to $681.66, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

5. Share total includes dividend credits earned on prior outstanding grants.

Remarks:

	George P. McDonald by Power of Attorney from Robert F. Freda	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Curtiss-Wright (CW) report for Robert F. Freda?

The filing shows 296 restricted stock units vesting into common stock on March 16, 2026, followed by an open-market sale of 140 common shares on March 17, 2026. Both positions are reported as directly owned after these transactions.

How many Curtiss-Wright (CW) shares does Robert F. Freda hold after this Form 4?

After the reported transactions, Robert F. Freda directly holds 5,343 shares of Curtiss-Wright common stock. This total includes dividend credits earned on prior outstanding equity grants, as specifically noted in the filing’s footnotes.

What was the nature of the RSU vesting reported for Curtiss-Wright (CW)?

296 restricted stock units granted on March 16, 2023, under Curtiss-Wright’s 2014 Omnibus Incentive Plan cliff vested into common stock after a three-year vesting period. The RSUs converted at a zero exercise price as an employee benefit transaction.

At what price were Curtiss-Wright (CW) shares sold in this Form 4?

The 140 common shares were sold at an average price of $678.61 per share. The filing notes multiple trades occurred in a price range from $671.23 to $681.66, and detailed trade-by-trade information is available upon request.

Why did Curtiss-Wright executive Robert F. Freda sell shares in this filing?

Footnotes state the 140-share sale was executed to cover tax obligations associated with the vesting equity award, in accordance with Curtiss-Wright’s share ownership guidelines. The filing emphasizes that Freda remains in compliance with those ownership requirements after the sale.

Were the Curtiss-Wright (CW) RSUs in this Form 4 granted as compensation?

Yes. The vesting restricted stock units were granted under Curtiss-Wright’s 2014 Omnibus Incentive Plan as an employee benefit transaction. The filing notes there was no price on the date of issue, consistent with standard equity compensation grants.